Cedar Mountain Advisors’s Gilead Sciences GILD Stock Holding History

Cedar Mountain Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.2K	Hold	271	–	–	0.01%	235
2026 Q1	$37.8K	Buy	271 +234	+632%	+$32.8K	0.01%	184
2025 Q4	$4.54K	Buy	37 +6	+19%	+$729	﹤0.01%	330
2025 Q3	$3.44K	Buy	+31	New	+$3.52K	﹤0.01%	366
2022 Q2	–	Sell	-151	Closed	-$9K	–	314
2022 Q1	$9K	Hold	151	–	–	﹤0.01%	182
2021 Q4	$11K	Hold	151	–	–	﹤0.01%	165
2021 Q3	$11K	Buy	+151	New	+$10.6K	﹤0.01%	156

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Cedar Mountain Advisors's GILD Position: Q2 2026 in Review

Cedar Mountain Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 271 shares worth $34.2K. The position accounts for 0.01% of the portfolio, ranked #235.

Cedar Mountain Advisors first reported a position in GILD in Q3 2021 and has held it in 7 quarters since. The position peaked at $37.8K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Cedar Mountain Advisors held 271 shares of Gilead Sciences worth $34.2K as of Q2 2026.
Cedar Mountain Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #235 holding.
Cedar Mountain Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 7 quarters since.
Cedar Mountain Advisors's Gilead Sciences position peaked at $37.8K in Q1 2026.
361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.